Accelerating
Precision Oncology
From translational research to clinical development to commercialization, we meet your needs at every stage of drug development.
Power Your Drug Development Decision-Making With InfinityAI
InfinityAI is our purpose-built artificial intelligence and machine learning technology that transforms Guardant Health’s rich multiomic datasets with clinical data into real-world evidence and actionable insights.
InfinityAI powers our diagnostic tests and applications across biopharma, healthcare institutions, and healthcare providers to enable better outcomes, improve practice efficiency, and inform smarter clinical decision making.
Our Clinical Testing Volume Keeps Our InfinityAI Data Library Growing
Unique Patients
Patients With >1 test, Providing Dynamic Serial Data
Get the Answers You Need at All Phases of Drug Development
Translational Research
Generate and validate research hypotheses to identify the right patients for therapy.
Clinical Development
Improve trial processes, predict clinical trial outcomes, and accelerate trial recruitment.
Commercialization
Optimize launch strategy and characterize unmet needs with real-world populations to inform product life-cycle planning.
A Robust Data Engine for Actionable Insights
InfinityAI enables the identification of novel biomarker-defined patient populations at scale by harmonizing longitudinal multimodal genomic and clinical data into a unified dataset. Powered by a purpose-built data engine, InfinityAI generates high-quality, real-world evidence, including novel biomarker discovery, to biopharma partners.
Mapping the Longitudinal Patient Journey With Real-World Evidence
The InfinityAI data library reconstructs a metastatic non-small cell lung cancer (mNSCLC) patient journey and assesses real-world duration of first-line advanced non-small cell lung cancer (aNSCLC) targeted therapy following circulating tumor DNA (ctDNA) biomarker identification.1
Leveraging the InfinityAI data library allows you to derive standard clinical endpoints such as:
Overall Survival (OS)
Time to Next Treatment (TTNT)
Time to Treatment Discontinuation (TTD)
Duration of Treatment (DoT)